Evidence map›Paper›PMID 35432864›Full record

ReviewChemical science2022

Catalysis with cycloruthenated complexes.

Michael T Findlay, Pablo Domingo-Legarda, Gillian McArthur, Andy Yen, Igor Larrosa

Abstract readReview
In one paragraph

Review in Chemical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Cycloruthenated Imines: A Step into the Nanomolar Region.Molecules (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Improving the sustainability of the ruthenium-catalysedGreen chemistry : an international journal and green chemistry resource : GC · 2023
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael T FindlaySchool of Chemistry, University of Manchester Oxford Road Manchester M13 9PL UK igor.larrosa@manchester.ac.uk.ORCID https://orcid.org/0000-0003-2508-6165
Pablo Domingo-LegardaSchool of Chemistry, University of Manchester Oxford Road Manchester M13 9PL UK igor.larrosa@manchester.ac.uk.ORCID https://orcid.org/0000-0003-0042-0411
Gillian McArthurSchool of Chemistry, University of Manchester Oxford Road Manchester M13 9PL UK igor.larrosa@manchester.ac.uk.ORCID https://orcid.org/0000-0001-7032-3604
Andy YenSchool of Chemistry, University of Manchester Oxford Road Manchester M13 9PL UK igor.larrosa@manchester.ac.uk.
Igor LarrosaSchool of Chemistry, University of Manchester Oxford Road Manchester M13 9PL UK igor.larrosa@manchester.ac.uk.ORCID https://orcid.org/0000-0002-5391-7424

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cycloruthenated complexes have been studied extensively over the last few decades. Many accounts of their synthesis, characterisation, and catalytic activity in a wide variety of transformations have been reported to date. Compared with their non-cyclometallated analogues, cycloruthenated complexes may display enhanced catalytic activities in known transformations or possess entirely new reactivity. In other instances, these complexes can be chiral, and capable of catalysing stereoselective reactions. In this review, we aim to highlight the catalytic applications of cycloruthenated complexes in organic synthesis, emphasising the recent advancements in this field.

Identifiers

PMID35432864
PMCPMC8943884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.